Very Long Chain Acyl Coa Dehydrogenase Deficiency: Clinical Trials

3 trials for Very Long Chain Acyl Coa Dehydrogenase Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Phase 21Completed 1

Follow Very Long Chain Acyl Coa Dehydrogenase Deficiency: new trials by email Literature Review of Very Long Chain Acyl Coa Dehydrogenase Deficiency trials Research Report on Very Long Chain Acyl Coa Dehydrogenase Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders
Nutritional Ketone Supplement, Isocaloric Placebo Supplement - Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, Carnitine Palmitoyltransferase Deficiency 2
Early Phase 1CompletedOregon Health and Science University52022-08-012024-04-02
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
Bezafibrate, Placebo - Carnitine Palmitoyltransferase II Deficiency, Very Long Chain Acyl Coa Dehydrogenase Deficiency
Phase 2CompletedCopenhagen University Hospital, Rigshospitalet122009-10-012012-05-30

Narrower conditions

Carnitine palmitoyl transferase 2 deficiency (3)  ·  VLCAD deficiency (3)  ·  Trifunctional Protein Deficiency With Myopathy And Neuropathy (2)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxyacyl-CoA Dehydrogenase Deficiency (1)  ·  3-methylcrotonyl CoA carboxylase 1 deficiency (1)  ·  3-methylcrotonyl CoA carboxylase 2 deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acrodermatitis enteropathica (1)  ·  Adenine phosphoribosyltransferase deficiency (1)  ·  Adrenal hyperplasia, congenital, type 5 (1)  ·  Adrenocorticotropic hormone deficiency (1)  ·  Amaurosis congenita of Leber, type 2 (1)  ·  Anemia, Sickle Cell (1)  ·  Angelman Syndrome (1)

Broader conditions

Abnormalities, Multiple (1)  ·  Albinism (1)  ·  Albinism, Oculocutaneous (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Arrhythmias, Cardiac (1)  ·  Avitaminosis (1)  ·  Basal Ganglia Diseases (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Blood Platelet Disorders (1)

Interventions

Bezafibrate (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  Oregon Health and Science University (1)  ·  RTI International (1)

Countries

United States (2)  ·  Denmark (1)

Top investigators

Curt Scharfe, MD, PhD (1)

Results publications

PMID 31315600, PMID 35142618